COMPOUND F USED ORALLY IN PATIENTS WITH RHEUMATOID ARTHRITIS
- 22 March 1952
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 148 (12) , 981-987
- https://doi.org/10.1001/jama.1952.02930120003002
Abstract
Research from JAMA — COMPOUND F USED ORALLY IN PATIENTS WITH RHEUMATOID ARTHRITISKeywords
This publication has 7 references indexed in Scilit:
- The Effect of a Hormone of the Adrenal Cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of Pituitary Adrenocorticotropic Hormone on Rheumatoid Arthritis: Preliminary reportMayo Clinic Proceedings, 2024
- Clinical and Metabolic Study of 17-Hydroxycorticosterone (Kendall Compound F); Comparison with Cortisone.Experimental Biology and Medicine, 1951
- ORAL USE OF CORTISONE ACETATEJAMA, 1951
- CLINICAL STUDIES WITH PITUITARY ADRENOCORTICOTROPINJournal of Clinical Endocrinology & Metabolism, 1948
- COMPARISON OF LIVER-GLYCOGEN DEPOSITION AND WORK PERFORMANCE TESTS FOR THE BIO-ASSAY OF ADRENAL CORTEX HORMONESEndocrinology, 1947
- THE RELATIVE POTENCY OF SOME ADRENAL CORTICAL STEROIDS IN THE MUSCLE-WORK TESTEndocrinology, 1945
- THE GLYCOGENIC ACTIVITY OF CERTAIN CRYSTALLINE STEROIDS OF THE ADRENAL CORTEX WHEN ADMINISTERED SINGLY AND WITH CORTICAL EXTRACT TO FASTED, NORMAL AND ADRENALECTOMIZED RATS1Endocrinology, 1944